144 related articles for article (PubMed ID: 3393649)
1. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
Stark DD; Weissleder R; Elizondo G; Hahn PF; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Aug; 168(2):297-301. PubMed ID: 3393649
[TBL] [Abstract][Full Text] [Related]
2. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Marchal G; Van Hecke P; Demaerel P; Decrop E; Kennis C; Baert AL; van der Schueren E
AJR Am J Roentgenol; 1989 Apr; 152(4):771-5. PubMed ID: 2784260
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
Rummeny E; Weissleder R; Stark DD; Elizondo G; Ferrucci JT
Radiologe; 1988 Aug; 28(8):380-6. PubMed ID: 3174975
[TBL] [Abstract][Full Text] [Related]
4. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.
Saini S; Stark DD; Hahn PF; Bousquet JC; Introcasso J; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):217-22. PubMed ID: 3786766
[TBL] [Abstract][Full Text] [Related]
5. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
[TBL] [Abstract][Full Text] [Related]
6. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats.
Weissleder R; Stark DD; Compton CC; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Dec; 149(6):1161-5. PubMed ID: 3318339
[TBL] [Abstract][Full Text] [Related]
7. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
Weissleder R; Hahn PF; Stark DD; Elizondo G; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Nov; 169(2):399-403. PubMed ID: 3174987
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging.
Kawamori Y; Matsui O; Kadoya M; Yoshikawa J; Demachi H; Takashima T
Radiology; 1992 Apr; 183(1):65-72. PubMed ID: 1549696
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide.
Vidiri A; Carpanese L; Annibale MD; Caterino M; Cosimelli M; Zeuli M; David V; Crecco M
J Exp Clin Cancer Res; 2004 Mar; 23(1):53-60. PubMed ID: 15149151
[TBL] [Abstract][Full Text] [Related]
11. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
[TBL] [Abstract][Full Text] [Related]
12. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.
Saini S; Stark DD; Hahn PF; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):211-6. PubMed ID: 3786765
[TBL] [Abstract][Full Text] [Related]
13. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis.
Ward J; Chen F; Guthrie JA; Wilson D; Lodge JP; Wyatt JI; Robinson PJ
Radiology; 2000 Jan; 214(1):159-66. PubMed ID: 10644117
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of splenic metastases: ferrite-enhanced detection in rats.
Weissleder R; Hahn PF; Stark DD; Rummeny E; Saini S; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Oct; 149(4):723-6. PubMed ID: 3498320
[TBL] [Abstract][Full Text] [Related]
15. Hepatic micrometastases in the rat: ferrite-enhanced MR imaging.
Tsang YM; Stark DD; Chen MC; Weissleder R; Wittenberg J; Ferrucci JT
Radiology; 1988 Apr; 167(1):21-4. PubMed ID: 3347724
[TBL] [Abstract][Full Text] [Related]
16. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
17. Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration.
Bacon BR; Stark DD; Park CH; Saini S; Groman EV; Hahn PF; Compton CC; Ferrucci JT
J Lab Clin Med; 1987 Aug; 110(2):164-71. PubMed ID: 3598345
[TBL] [Abstract][Full Text] [Related]
18. Splenic lymphoma: ferrite-enhanced MR imaging in rats.
Weissleder R; Stark DD; Rummeny EJ; Compton CC; Ferrucci JT
Radiology; 1988 Feb; 166(2):423-30. PubMed ID: 3336717
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging].
Hirohashi S; Uchida H; Ohimichi R; Kitano S; Tanaka M; Ohishi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):469-71. PubMed ID: 8388092
[TBL] [Abstract][Full Text] [Related]
20. Kupffer cell function of hepatocellular adenoma: pulse sequence effects in superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Akatsu T; Ueda M; Shimazu M; Wakabayashi G; Aiura K; Tanabe M; Kawachi S; Tanimoto A; Shinmoto H; Sakamoto M; Kitajima M
J Gastroenterol Hepatol; 2004 Aug; 19(8):951-2. PubMed ID: 15242510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
